For the future unfolding of the stock market and the appropriate actions to be taken for maximum gains, top brokerages play out prophesizing. JPMorgan gave out overweight ratings (anticipating security in future market) to DLF and Prestige Estate, putting target prices of ₹490 and ₹635 respectively. Kotak Institutional Equities recommended a ‘buy’ with target price of ₹1,590 on the Krishna Institute of Medical Sciences, anticipating a 17.9% Ebitda CAGR in the upcoming period; while ICICI Securities, with a target price of ₹1,769, called a ‘buy’ rating on Torrent Pharma.
